WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001088147) A NOVEL POLYPEPTIDE, A HUMAN TYROSINE KINASE 14 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/088147    International Application No.:    PCT/CN2001/000715
Publication Date: 22.11.2001 International Filing Date: 08.05.2001
IPC:
C12N 9/12 (2006.01)
Applicants: SHANGHAI BIOWINDOW GENE DEVELOPMENT INC. [CN/CN]; 12th Floor 3rd Building 1111 Zhongshan Bei Road Shanghai 200092 (CN) (For All Designated States Except US).
MAO, Yumin [CN/CN]; (CN) (For US Only).
XIE, Yi [CN/CN]; (CN) (For US Only)
Inventors: MAO, Yumin; (CN).
XIE, Yi; (CN)
Agent: SHANGHAI HUA DONG PATENT AGENCY; 319 Yue Yang Road Shanghai 200031 (CN)
Priority Data:
00115618.7 09.05.2000 CN
Title (EN) A NOVEL POLYPEPTIDE, A HUMAN TYROSINE KINASE 14 AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
(FR) POLYPEPTIDE DE TYROSINE KINASE 14 HUMAINE ET POLYNUCLEOTIDE LE CODANT
Abstract: front page image
(EN)The present invention discloses a novel polypeptide, a human tyrosine kinase 14, the polynucleotide encoding the polypeptide and the method for producing the polypeptide by DNA recombinant technology. The invention also discloses the uses of the polypeptide in methods for treating various diseases, such as malignant tumour, hemopathy, developmental disorder, HIV infection, immunological disease, and various inflammation, etc. The invention also discloses the agonists against the polypeptide and the therapeutic action thereof. The invention also discloses the uses of the polynucleotide encoding the novel human tyrosine kinase 14.
(FR)L'invention concerne un polypeptide de tyrosine kinase 14 humaine, le polynucléotide le codant et le procédé de production de ce polypeptide à l'aide de technologie de recombinaison d'ADN. Elle concerne aussi les utilisations du polypeptide dans des méthodes de traitement de maladies variées, telles que tumeur maligne, hémopathie, trouble du développement, infection VIH, maladie immunologique, inflammations diverses, et d'autres. Elle concerne encore les agonistes dirigés contre le polypeptide et leur action thérapeutique. Elle concerne enfin les utilisations du polynucléotide codant la tyrosine kinase 14 humaine.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CO, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)